We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Top Buys

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$74.4M
2
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$42.5M
3
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$24.2M
4
SMH icon
VanEck Semiconductor ETF
SMH
+$17.4M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$12.9M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$105M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.8M
4
MSFT icon
Microsoft
MSFT
+$12.8M
5
AAPL icon
Apple
AAPL
+$11.9M

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMPY icon
3626
Amplify Energy
AMPY
$166M
– –
-799
Closed -$8K
APPF icon
3627
AppFolio
APPF
$7.04B
– –
-25
Closed -$2K
AQMS icon
3628
Aqua Metals
AQMS
$10.2M
– –
-13
Closed -$5.73K
AQST icon
3629
Aquestive Therapeutics
AQST
$494M
– –
-951
Closed -$7K
ARCC icon
3630
Ares Capital
ARCC
$14.4B
– –
-6,842
Closed -$117K
ARCT icon
3631
Arcturus Therapeutics
ARCT
$211M
$0 ﹤0.01%
+52
New +$382
ARDX icon
3632
Ardelyx
ARDX
$988M
– –
-5,334
Closed -$15K
ARES icon
3633
Ares Management
ARES
$30.9B
– –
-1,147
Closed -$27K
ARGX icon
3634
argenx
ARGX
$54.1B
– –
-17
Closed -$2K
ARI
3635
Apollo Commercial Real Estate
ARI
$885M
– –
-2,819
Closed -$51K
ARKR icon
3636
Ark Restaurants
ARKR
$20.2M
– –
-376
Closed -$7K
ARLP icon
3637
Alliance Resource Partners
ARLP
$3.17B
– –
-1,295
Closed -$26K
AROC icon
3638
Archrock
AROC
$5.8B
– –
-4,271
Closed -$42K
AROW icon
3639
Arrow Financial
AROW
$652M
– –
-328
Closed -$9K
ARTL icon
3640
Artelo Biosciences
ARTL
$2.51M
– –
0
– –
ARTNA icon
3641
Artesian Resources
ARTNA
$358M
– –
-198
Closed -$7K
ARVN icon
3642
Arvinas
ARVN
$572M
– –
-311
Closed -$5K
ASC icon
3643
Ardmore Shipping
ASC
$683M
– –
-435
Closed -$3K
ASPN icon
3644
Aspen Aerogels
ASPN
$518M
$0 ﹤0.01%
42
-398
-90% -$1.81K
ASPS icon
3645
Altisource Portfolio Solutions
ASPS
$65.8M
– –
-576
Closed -$109K
ASYS icon
3646
Amtech Systems
ASYS
$272M
$0 ﹤0.01%
75
-8,639
-99% -$52.7K
ATHM icon
3647
Autohome
ATHM
$2.62B
– –
-1,209
Closed -$127K
ATLC icon
3648
Atlanticus Holdings
ATLC
$1.51B
– –
-154
Closed -$1K
ATMP icon
3649
iPath Select MLP ETN
ATMP
$621M
– –
-11
Closed –
FRMM
3650
Forum Markets
FRMM
$79.5M
– –
0
– –
144 145
146
147 148

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.